APA (7th ed.) Citation

Wang, X., Su, Y., Lan, B., Li, X., Zhang, B., Zhang, L., . . . Xuan, C. (2025). USP22 promotes the proliferation and Sorafenib resistance of hepatocellular carcinoma cells via its deubiquitinase activity. Clinical and Translational Medicine, 15(5), . https://doi.org/10.1002/ctm2.70324

Chicago Style (17th ed.) Citation

Wang, Xiaochen, Yijie Su, Bei Lan, Xuanyuan Li, Bodi Zhang, Liang Zhang, Yingmei Wang, Chunze Zhang, and Chenghao Xuan. "USP22 Promotes the Proliferation and Sorafenib Resistance of Hepatocellular Carcinoma Cells via Its Deubiquitinase Activity." Clinical and Translational Medicine 15, no. 5 (2025). https://doi.org/10.1002/ctm2.70324.

MLA (9th ed.) Citation

Wang, Xiaochen, et al. "USP22 Promotes the Proliferation and Sorafenib Resistance of Hepatocellular Carcinoma Cells via Its Deubiquitinase Activity." Clinical and Translational Medicine, vol. 15, no. 5, 2025, https://doi.org/10.1002/ctm2.70324.